nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—ABCB1—colon cancer	0.338	1	CbGaD
Methadone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0485	0.0966	CbGbCtD
Methadone—CYP3A7—Irinotecan—colon cancer	0.0485	0.0966	CbGbCtD
Methadone—CYP2B6—Irinotecan—colon cancer	0.0462	0.092	CbGbCtD
Methadone—CYP3A7—Vincristine—colon cancer	0.0424	0.0844	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0424	0.0844	CbGbCtD
Methadone—CYP2C9—Capecitabine—colon cancer	0.0395	0.0787	CbGbCtD
Methadone—CYP3A5—Irinotecan—colon cancer	0.0364	0.0725	CbGbCtD
Methadone—CYP2C8—Fluorouracil—colon cancer	0.0336	0.0669	CbGbCtD
Methadone—CYP3A5—Vincristine—colon cancer	0.0318	0.0633	CbGbCtD
Methadone—CYP1A2—Fluorouracil—colon cancer	0.026	0.0518	CbGbCtD
Methadone—ABCB1—Irinotecan—colon cancer	0.0237	0.0472	CbGbCtD
Methadone—CYP2C9—Fluorouracil—colon cancer	0.0234	0.0466	CbGbCtD
Methadone—ABCB1—Vincristine—colon cancer	0.0207	0.0412	CbGbCtD
Methadone—CYP3A4—Irinotecan—colon cancer	0.0142	0.0283	CbGbCtD
Methadone—ABCB1—Methotrexate—colon cancer	0.0125	0.025	CbGbCtD
Methadone—CYP3A4—Vincristine—colon cancer	0.0124	0.0247	CbGbCtD
Methadone—HTR3A—myenteric nerve plexus—colon cancer	0.0118	0.305	CbGeAlD
Methadone—Chronic hepatitis—Methotrexate—colon cancer	0.00942	0.0789	CcSEcCtD
Methadone—Piloerection—Irinotecan—colon cancer	0.00657	0.055	CcSEcCtD
Methadone—Miosis—Irinotecan—colon cancer	0.00273	0.0228	CcSEcCtD
Methadone—Cardiomyopathy—Fluorouracil—colon cancer	0.00213	0.0179	CcSEcCtD
Methadone—CHRNA10—lymphoid tissue—colon cancer	0.00195	0.0505	CbGeAlD
Methadone—Lacrimation—Irinotecan—colon cancer	0.00194	0.0162	CcSEcCtD
Methadone—Lacrimation—Fluorouracil—colon cancer	0.00186	0.0155	CcSEcCtD
Methadone—Hypomagnesaemia—Irinotecan—colon cancer	0.00179	0.015	CcSEcCtD
Methadone—Abdominal cramps—Vincristine—colon cancer	0.00173	0.0145	CcSEcCtD
Methadone—CHRNA10—vagina—colon cancer	0.0017	0.044	CbGeAlD
Methadone—Abdominal cramps—Irinotecan—colon cancer	0.00169	0.0141	CcSEcCtD
Methadone—Lung disorder—Irinotecan—colon cancer	0.00161	0.0135	CcSEcCtD
Methadone—Cardiomyopathy—Capecitabine—colon cancer	0.00149	0.0125	CcSEcCtD
Methadone—OPRD1—renal system—colon cancer	0.00146	0.0378	CbGeAlD
Methadone—Sneezing—Capecitabine—colon cancer	0.00138	0.0115	CcSEcCtD
Methadone—CYP2C18—digestive system—colon cancer	0.00133	0.0343	CbGeAlD
Methadone—Drug interaction—Vincristine—colon cancer	0.00126	0.0106	CcSEcCtD
Methadone—Lacrimation increased—Irinotecan—colon cancer	0.00124	0.0103	CcSEcCtD
Methadone—Hypomagnesaemia—Capecitabine—colon cancer	0.0012	0.01	CcSEcCtD
Methadone—Lacrimation increased—Fluorouracil—colon cancer	0.00118	0.00991	CcSEcCtD
Methadone—CYP2C18—vagina—colon cancer	0.00117	0.0303	CbGeAlD
Methadone—CHRNA10—lymph node—colon cancer	0.0011	0.0285	CbGeAlD
Methadone—Torsade de pointes—Capecitabine—colon cancer	0.00109	0.0091	CcSEcCtD
Methadone—Dermatitis contact—Fluorouracil—colon cancer	0.00108	0.00903	CcSEcCtD
Methadone—Osteoporosis—Methotrexate—colon cancer	0.00101	0.00848	CcSEcCtD
Methadone—Ventricular fibrillation—Capecitabine—colon cancer	0.000996	0.00834	CcSEcCtD
Methadone—CYP2C18—liver—colon cancer	0.000987	0.0256	CbGeAlD
Methadone—Fracture—Methotrexate—colon cancer	0.000977	0.00818	CcSEcCtD
Methadone—Multiple fractures—Methotrexate—colon cancer	0.000977	0.00818	CcSEcCtD
Methadone—Rhinorrhoea—Capecitabine—colon cancer	0.000941	0.00788	CcSEcCtD
Methadone—CYP3A7—liver—colon cancer	0.000939	0.0243	CbGeAlD
Methadone—Euphoric mood—Fluorouracil—colon cancer	0.000938	0.00785	CcSEcCtD
Methadone—Extrasystoles—Capecitabine—colon cancer	0.000906	0.00759	CcSEcCtD
Methadone—Swelling—Fluorouracil—colon cancer	0.000898	0.00752	CcSEcCtD
Methadone—HTR3A—digestive system—colon cancer	0.000891	0.0231	CbGeAlD
Methadone—Disorientation—Fluorouracil—colon cancer	0.000886	0.00741	CcSEcCtD
Methadone—Visual disturbance—Irinotecan—colon cancer	0.000873	0.00731	CcSEcCtD
Methadone—Lacrimation increased—Capecitabine—colon cancer	0.000828	0.00693	CcSEcCtD
Methadone—Cardiac failure—Fluorouracil—colon cancer	0.000812	0.00679	CcSEcCtD
Methadone—Urinary retention—Vincristine—colon cancer	0.000808	0.00676	CcSEcCtD
Methadone—Cardiac arrest—Vincristine—colon cancer	0.000808	0.00676	CcSEcCtD
Methadone—Lung disorder—Methotrexate—colon cancer	0.000802	0.00671	CcSEcCtD
Methadone—CYP3A7-CYP3A51P—liver—colon cancer	0.000799	0.0207	CbGeAlD
Methadone—Cardiac arrest—Irinotecan—colon cancer	0.000787	0.00658	CcSEcCtD
Methadone—Irritability—Fluorouracil—colon cancer	0.000756	0.00633	CcSEcCtD
Methadone—Orthostatic hypotension—Irinotecan—colon cancer	0.000756	0.00632	CcSEcCtD
Methadone—Cardiac arrest—Fluorouracil—colon cancer	0.000753	0.00631	CcSEcCtD
Methadone—Hypokalaemia—Irinotecan—colon cancer	0.000753	0.0063	CcSEcCtD
Methadone—Nasopharyngitis—Fluorouracil—colon cancer	0.000708	0.00593	CcSEcCtD
Methadone—Sweating increased—Irinotecan—colon cancer	0.000696	0.00583	CcSEcCtD
Methadone—Weight decreased—Vincristine—colon cancer	0.000664	0.00556	CcSEcCtD
Methadone—Weight decreased—Irinotecan—colon cancer	0.000647	0.00541	CcSEcCtD
Methadone—Phlebitis—Capecitabine—colon cancer	0.000643	0.00538	CcSEcCtD
Methadone—ABCB1—blood vessel—colon cancer	0.000636	0.0165	CbGeAlD
Methadone—Swelling—Capecitabine—colon cancer	0.000628	0.00525	CcSEcCtD
Methadone—Sweating—Vincristine—colon cancer	0.000628	0.00525	CcSEcCtD
Methadone—Glossitis—Methotrexate—colon cancer	0.000616	0.00516	CcSEcCtD
Methadone—Sweating—Irinotecan—colon cancer	0.000611	0.00511	CcSEcCtD
Methadone—CYP2C8—renal system—colon cancer	0.000599	0.0155	CbGeAlD
Methadone—Libido decreased—Capecitabine—colon cancer	0.000597	0.005	CcSEcCtD
Methadone—Hallucination—Vincristine—colon cancer	0.000585	0.00489	CcSEcCtD
Methadone—Bradycardia—Irinotecan—colon cancer	0.000583	0.00488	CcSEcCtD
Methadone—Cardiac failure—Capecitabine—colon cancer	0.000567	0.00475	CcSEcCtD
Methadone—CYP2C19—digestive system—colon cancer	0.000563	0.0146	CbGeAlD
Methadone—CYP1A2—renal system—colon cancer	0.000561	0.0145	CbGeAlD
Methadone—Visual impairment—Irinotecan—colon cancer	0.000551	0.00462	CcSEcCtD
Methadone—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000549	0.0046	CcSEcCtD
Methadone—CYP3A5—renal system—colon cancer	0.000541	0.014	CbGeAlD
Methadone—CYP2B6—renal system—colon cancer	0.000538	0.0139	CbGeAlD
Methadone—Flushing—Irinotecan—colon cancer	0.000531	0.00445	CcSEcCtD
Methadone—Irritability—Capecitabine—colon cancer	0.000528	0.00442	CcSEcCtD
Methadone—Urinary retention—Capecitabine—colon cancer	0.000526	0.00441	CcSEcCtD
Methadone—Cardiac arrest—Capecitabine—colon cancer	0.000526	0.00441	CcSEcCtD
Methadone—Chills—Irinotecan—colon cancer	0.000513	0.0043	CcSEcCtD
Methadone—CYP19A1—liver—colon cancer	0.000512	0.0132	CbGeAlD
Methadone—Arrhythmia—Irinotecan—colon cancer	0.000511	0.00428	CcSEcCtD
Methadone—Orthostatic hypotension—Capecitabine—colon cancer	0.000506	0.00423	CcSEcCtD
Methadone—Pulmonary oedema—Methotrexate—colon cancer	0.000505	0.00423	CcSEcCtD
Methadone—Hypokalaemia—Capecitabine—colon cancer	0.000504	0.00422	CcSEcCtD
Methadone—CYP2C19—vagina—colon cancer	0.000497	0.0129	CbGeAlD
Methadone—Nasopharyngitis—Capecitabine—colon cancer	0.000495	0.00414	CcSEcCtD
Methadone—Arrhythmia—Fluorouracil—colon cancer	0.00049	0.0041	CcSEcCtD
Methadone—Muscle spasms—Irinotecan—colon cancer	0.000479	0.00401	CcSEcCtD
Methadone—Erythema—Fluorouracil—colon cancer	0.000477	0.00399	CcSEcCtD
Methadone—Agitation—Vincristine—colon cancer	0.00047	0.00393	CcSEcCtD
Methadone—Sweating increased—Capecitabine—colon cancer	0.000466	0.0039	CcSEcCtD
Methadone—CYP1A2—digestive system—colon cancer	0.00046	0.0119	CbGeAlD
Methadone—Vertigo—Vincristine—colon cancer	0.00046	0.00385	CcSEcCtD
Methadone—Vertigo—Irinotecan—colon cancer	0.000448	0.00375	CcSEcCtD
Methadone—Syncope—Irinotecan—colon cancer	0.000447	0.00374	CcSEcCtD
Methadone—CYP2B6—lymphoid tissue—colon cancer	0.000446	0.0116	CbGeAlD
Methadone—CYP3A5—digestive system—colon cancer	0.000444	0.0115	CbGeAlD
Methadone—Convulsion—Vincristine—colon cancer	0.000443	0.00371	CcSEcCtD
Methadone—CYP2B6—digestive system—colon cancer	0.000441	0.0114	CbGeAlD
Methadone—Loss of consciousness—Irinotecan—colon cancer	0.000438	0.00366	CcSEcCtD
Methadone—CYP2C9—digestive system—colon cancer	0.000437	0.0113	CbGeAlD
Methadone—Weight increased—Capecitabine—colon cancer	0.000435	0.00364	CcSEcCtD
Methadone—Visual disturbance—Methotrexate—colon cancer	0.000435	0.00364	CcSEcCtD
Methadone—CYP2C8—vagina—colon cancer	0.000434	0.0112	CbGeAlD
Methadone—Weight decreased—Capecitabine—colon cancer	0.000433	0.00362	CcSEcCtD
Methadone—CYP2C19—liver—colon cancer	0.00042	0.0109	CbGeAlD
Methadone—Anaphylactic shock—Vincristine—colon cancer	0.000417	0.00349	CcSEcCtD
Methadone—Oedema—Vincristine—colon cancer	0.000417	0.00349	CcSEcCtD
Methadone—Convulsion—Fluorouracil—colon cancer	0.000413	0.00346	CcSEcCtD
Methadone—Confusional state—Irinotecan—colon cancer	0.00041	0.00343	CcSEcCtD
Methadone—Thrombocytopenia—Vincristine—colon cancer	0.000409	0.00342	CcSEcCtD
Methadone—Anaphylactic shock—Irinotecan—colon cancer	0.000407	0.0034	CcSEcCtD
Methadone—Oedema—Irinotecan—colon cancer	0.000407	0.0034	CcSEcCtD
Methadone—CYP3A4—renal system—colon cancer	0.000406	0.0105	CbGeAlD
Methadone—Hyperhidrosis—Vincristine—colon cancer	0.000404	0.00338	CcSEcCtD
Methadone—Shock—Irinotecan—colon cancer	0.0004	0.00335	CcSEcCtD
Methadone—CYP2D6—renal system—colon cancer	0.000399	0.0103	CbGeAlD
Methadone—Thrombocytopenia—Irinotecan—colon cancer	0.000398	0.00333	CcSEcCtD
Methadone—Anorexia—Vincristine—colon cancer	0.000398	0.00333	CcSEcCtD
Methadone—Irritability—Methotrexate—colon cancer	0.000393	0.00329	CcSEcCtD
Methadone—Hyperhidrosis—Irinotecan—colon cancer	0.000393	0.00329	CcSEcCtD
Methadone—Confusional state—Fluorouracil—colon cancer	0.000393	0.00329	CcSEcCtD
Methadone—CYP19A1—lymph node—colon cancer	0.000392	0.0102	CbGeAlD
Methadone—CYP3A5—vagina—colon cancer	0.000392	0.0101	CbGeAlD
Methadone—Hypotension—Vincristine—colon cancer	0.00039	0.00326	CcSEcCtD
Methadone—Bradycardia—Capecitabine—colon cancer	0.00039	0.00326	CcSEcCtD
Methadone—CYP2B6—vagina—colon cancer	0.000389	0.0101	CbGeAlD
Methadone—Anaphylactic shock—Fluorouracil—colon cancer	0.000389	0.00326	CcSEcCtD
Methadone—Oedema—Fluorouracil—colon cancer	0.000389	0.00326	CcSEcCtD
Methadone—Anorexia—Irinotecan—colon cancer	0.000388	0.00324	CcSEcCtD
Methadone—Oxaprozin—PTGS2—colon cancer	0.000385	0.219	CrCbGaD
Methadone—Thrombocytopenia—Fluorouracil—colon cancer	0.000381	0.00319	CcSEcCtD
Methadone—Tachycardia—Fluorouracil—colon cancer	0.00038	0.00318	CcSEcCtD
Methadone—Hypotension—Irinotecan—colon cancer	0.00038	0.00318	CcSEcCtD
Methadone—ABCB1—embryo—colon cancer	0.00038	0.00983	CbGeAlD
Methadone—Insomnia—Vincristine—colon cancer	0.000378	0.00316	CcSEcCtD
Methadone—Anorexia—Fluorouracil—colon cancer	0.000371	0.00311	CcSEcCtD
Methadone—Visual impairment—Capecitabine—colon cancer	0.000369	0.00309	CcSEcCtD
Methadone—Insomnia—Irinotecan—colon cancer	0.000368	0.00308	CcSEcCtD
Methadone—CYP2C8—liver—colon cancer	0.000366	0.00948	CbGeAlD
Methadone—Hypotension—Fluorouracil—colon cancer	0.000364	0.00305	CcSEcCtD
Methadone—Decreased appetite—Vincristine—colon cancer	0.000363	0.00304	CcSEcCtD
Methadone—Somnolence—Irinotecan—colon cancer	0.000361	0.00303	CcSEcCtD
Methadone—Pain—Vincristine—colon cancer	0.000357	0.00299	CcSEcCtD
Methadone—Constipation—Vincristine—colon cancer	0.000357	0.00299	CcSEcCtD
Methadone—Flushing—Capecitabine—colon cancer	0.000355	0.00297	CcSEcCtD
Methadone—Decreased appetite—Irinotecan—colon cancer	0.000353	0.00296	CcSEcCtD
Methadone—Insomnia—Fluorouracil—colon cancer	0.000352	0.00295	CcSEcCtD
Methadone—Pain—Irinotecan—colon cancer	0.000348	0.00291	CcSEcCtD
Methadone—Constipation—Irinotecan—colon cancer	0.000348	0.00291	CcSEcCtD
Methadone—Somnolence—Fluorouracil—colon cancer	0.000346	0.0029	CcSEcCtD
Methadone—Chills—Capecitabine—colon cancer	0.000344	0.00288	CcSEcCtD
Methadone—CYP1A2—liver—colon cancer	0.000343	0.00887	CbGeAlD
Methadone—Arrhythmia—Capecitabine—colon cancer	0.000342	0.00286	CcSEcCtD
Methadone—Gastrointestinal pain—Vincristine—colon cancer	0.000341	0.00286	CcSEcCtD
Methadone—Decreased appetite—Fluorouracil—colon cancer	0.000338	0.00283	CcSEcCtD
Methadone—Feeling abnormal—Irinotecan—colon cancer	0.000335	0.0028	CcSEcCtD
Methadone—Erythema—Capecitabine—colon cancer	0.000333	0.00279	CcSEcCtD
Methadone—Pain—Fluorouracil—colon cancer	0.000333	0.00279	CcSEcCtD
Methadone—CYP3A4—digestive system—colon cancer	0.000333	0.00862	CbGeAlD
Methadone—Gastrointestinal pain—Irinotecan—colon cancer	0.000332	0.00278	CcSEcCtD
Methadone—CYP3A5—liver—colon cancer	0.000331	0.00856	CbGeAlD
Methadone—Abdominal pain—Vincristine—colon cancer	0.00033	0.00276	CcSEcCtD
Methadone—Body temperature increased—Vincristine—colon cancer	0.00033	0.00276	CcSEcCtD
Methadone—CYP2B6—liver—colon cancer	0.000329	0.0085	CbGeAlD
Methadone—CYP2D6—digestive system—colon cancer	0.000328	0.00848	CbGeAlD
Methadone—CYP2C9—liver—colon cancer	0.000325	0.00842	CbGeAlD
Methadone—Abdominal pain—Irinotecan—colon cancer	0.000321	0.00269	CcSEcCtD
Methadone—Body temperature increased—Irinotecan—colon cancer	0.000321	0.00269	CcSEcCtD
Methadone—Feeling abnormal—Fluorouracil—colon cancer	0.000321	0.00269	CcSEcCtD
Methadone—Muscle spasms—Capecitabine—colon cancer	0.000321	0.00268	CcSEcCtD
Methadone—Drowsiness—Methotrexate—colon cancer	0.000318	0.00266	CcSEcCtD
Methadone—Tremor—Capecitabine—colon cancer	0.000312	0.00261	CcSEcCtD
Methadone—ABCB1—epithelium—colon cancer	0.00031	0.00802	CbGeAlD
Methadone—Urticaria—Fluorouracil—colon cancer	0.000309	0.00259	CcSEcCtD
Methadone—Body temperature increased—Fluorouracil—colon cancer	0.000308	0.00258	CcSEcCtD
Methadone—Hypersensitivity—Vincristine—colon cancer	0.000308	0.00257	CcSEcCtD
Methadone—Sweating—Methotrexate—colon cancer	0.000304	0.00255	CcSEcCtD
Methadone—Vertigo—Capecitabine—colon cancer	0.0003	0.00251	CcSEcCtD
Methadone—Hypersensitivity—Irinotecan—colon cancer	0.0003	0.00251	CcSEcCtD
Methadone—Asthenia—Vincristine—colon cancer	0.0003	0.00251	CcSEcCtD
Methadone—Syncope—Capecitabine—colon cancer	0.000299	0.0025	CcSEcCtD
Methadone—Palpitations—Capecitabine—colon cancer	0.000295	0.00247	CcSEcCtD
Methadone—Loss of consciousness—Capecitabine—colon cancer	0.000293	0.00245	CcSEcCtD
Methadone—Asthenia—Irinotecan—colon cancer	0.000292	0.00244	CcSEcCtD
Methadone—ABCB1—renal system—colon cancer	0.000287	0.00744	CbGeAlD
Methadone—Hypersensitivity—Fluorouracil—colon cancer	0.000287	0.0024	CcSEcCtD
Methadone—Diarrhoea—Vincristine—colon cancer	0.000286	0.00239	CcSEcCtD
Methadone—Anxiety—Capecitabine—colon cancer	0.000283	0.00237	CcSEcCtD
Methadone—Diarrhoea—Irinotecan—colon cancer	0.000278	0.00233	CcSEcCtD
Methadone—Dry mouth—Capecitabine—colon cancer	0.000278	0.00232	CcSEcCtD
Methadone—Dizziness—Vincristine—colon cancer	0.000276	0.00231	CcSEcCtD
Methadone—Pruritus—Fluorouracil—colon cancer	0.000275	0.00231	CcSEcCtD
Methadone—Visual impairment—Methotrexate—colon cancer	0.000275	0.0023	CcSEcCtD
Methadone—Confusional state—Capecitabine—colon cancer	0.000274	0.0023	CcSEcCtD
Methadone—Oedema—Capecitabine—colon cancer	0.000272	0.00228	CcSEcCtD
Methadone—Dizziness—Irinotecan—colon cancer	0.000269	0.00225	CcSEcCtD
Methadone—Shock—Capecitabine—colon cancer	0.000268	0.00224	CcSEcCtD
Methadone—Diarrhoea—Fluorouracil—colon cancer	0.000266	0.00223	CcSEcCtD
Methadone—Thrombocytopenia—Capecitabine—colon cancer	0.000266	0.00223	CcSEcCtD
Methadone—Tachycardia—Capecitabine—colon cancer	0.000266	0.00222	CcSEcCtD
Methadone—Vomiting—Vincristine—colon cancer	0.000265	0.00222	CcSEcCtD
Methadone—Rash—Vincristine—colon cancer	0.000263	0.0022	CcSEcCtD
Methadone—Hyperhidrosis—Capecitabine—colon cancer	0.000263	0.0022	CcSEcCtD
Methadone—Dermatitis—Vincristine—colon cancer	0.000263	0.0022	CcSEcCtD
Methadone—Headache—Vincristine—colon cancer	0.000262	0.00219	CcSEcCtD
Methadone—Anorexia—Capecitabine—colon cancer	0.000259	0.00217	CcSEcCtD
Methadone—Vomiting—Irinotecan—colon cancer	0.000259	0.00216	CcSEcCtD
Methadone—Dizziness—Fluorouracil—colon cancer	0.000257	0.00216	CcSEcCtD
Methadone—Rash—Irinotecan—colon cancer	0.000256	0.00215	CcSEcCtD
Methadone—Dermatitis—Irinotecan—colon cancer	0.000256	0.00214	CcSEcCtD
Methadone—Chills—Methotrexate—colon cancer	0.000256	0.00214	CcSEcCtD
Methadone—Headache—Irinotecan—colon cancer	0.000255	0.00213	CcSEcCtD
Methadone—Phenylbutazone—PTGS2—colon cancer	0.000254	0.145	CrCbGaD
Methadone—Hypotension—Capecitabine—colon cancer	0.000254	0.00213	CcSEcCtD
Methadone—Fexofenadine—ABCB1—colon cancer	0.000251	0.143	CrCbGaD
Methadone—Erythema—Methotrexate—colon cancer	0.000248	0.00208	CcSEcCtD
Methadone—CYP3A4—liver—colon cancer	0.000248	0.00642	CbGeAlD
Methadone—Nausea—Vincristine—colon cancer	0.000248	0.00208	CcSEcCtD
Methadone—Vomiting—Fluorouracil—colon cancer	0.000248	0.00207	CcSEcCtD
Methadone—Insomnia—Capecitabine—colon cancer	0.000246	0.00206	CcSEcCtD
Methadone—Rash—Fluorouracil—colon cancer	0.000246	0.00205	CcSEcCtD
Methadone—Dermatitis—Fluorouracil—colon cancer	0.000245	0.00205	CcSEcCtD
Methadone—CYP2D6—liver—colon cancer	0.000244	0.00632	CbGeAlD
Methadone—Headache—Fluorouracil—colon cancer	0.000244	0.00204	CcSEcCtD
Methadone—Nausea—Irinotecan—colon cancer	0.000241	0.00202	CcSEcCtD
Methadone—ABCB1—lymphoid tissue—colon cancer	0.000239	0.00618	CbGeAlD
Methadone—Decreased appetite—Capecitabine—colon cancer	0.000237	0.00198	CcSEcCtD
Methadone—ABCB1—digestive system—colon cancer	0.000236	0.0061	CbGeAlD
Methadone—Constipation—Capecitabine—colon cancer	0.000233	0.00195	CcSEcCtD
Methadone—Pain—Capecitabine—colon cancer	0.000233	0.00195	CcSEcCtD
Methadone—Nausea—Fluorouracil—colon cancer	0.000231	0.00194	CcSEcCtD
Methadone—Feeling abnormal—Capecitabine—colon cancer	0.000224	0.00188	CcSEcCtD
Methadone—Vertigo—Methotrexate—colon cancer	0.000223	0.00187	CcSEcCtD
Methadone—Gastrointestinal pain—Capecitabine—colon cancer	0.000223	0.00186	CcSEcCtD
Methadone—ABCB1—bone marrow—colon cancer	0.000217	0.00562	CbGeAlD
Methadone—Urticaria—Capecitabine—colon cancer	0.000216	0.00181	CcSEcCtD
Methadone—Abdominal pain—Capecitabine—colon cancer	0.000215	0.0018	CcSEcCtD
Methadone—Body temperature increased—Capecitabine—colon cancer	0.000215	0.0018	CcSEcCtD
Methadone—Convulsion—Methotrexate—colon cancer	0.000215	0.0018	CcSEcCtD
Methadone—ABCB1—vagina—colon cancer	0.000208	0.00539	CbGeAlD
Methadone—Confusional state—Methotrexate—colon cancer	0.000204	0.00171	CcSEcCtD
Methadone—Anaphylactic shock—Methotrexate—colon cancer	0.000203	0.0017	CcSEcCtD
Methadone—Hypersensitivity—Capecitabine—colon cancer	0.0002	0.00168	CcSEcCtD
Methadone—Thrombocytopenia—Methotrexate—colon cancer	0.000198	0.00166	CcSEcCtD
Methadone—Hyperhidrosis—Methotrexate—colon cancer	0.000196	0.00164	CcSEcCtD
Methadone—Asthenia—Capecitabine—colon cancer	0.000195	0.00163	CcSEcCtD
Methadone—Clotrimazole—ABCB1—colon cancer	0.000194	0.11	CrCbGaD
Methadone—Anorexia—Methotrexate—colon cancer	0.000193	0.00162	CcSEcCtD
Methadone—Pruritus—Capecitabine—colon cancer	0.000193	0.00161	CcSEcCtD
Methadone—Hypotension—Methotrexate—colon cancer	0.000189	0.00158	CcSEcCtD
Methadone—Diarrhoea—Capecitabine—colon cancer	0.000186	0.00156	CcSEcCtD
Methadone—Insomnia—Methotrexate—colon cancer	0.000183	0.00153	CcSEcCtD
Methadone—Somnolence—Methotrexate—colon cancer	0.00018	0.00151	CcSEcCtD
Methadone—Dizziness—Capecitabine—colon cancer	0.00018	0.00151	CcSEcCtD
Methadone—Decreased appetite—Methotrexate—colon cancer	0.000176	0.00147	CcSEcCtD
Methadone—ABCB1—liver—colon cancer	0.000176	0.00455	CbGeAlD
Methadone—Pain—Methotrexate—colon cancer	0.000173	0.00145	CcSEcCtD
Methadone—Vomiting—Capecitabine—colon cancer	0.000173	0.00145	CcSEcCtD
Methadone—Rash—Capecitabine—colon cancer	0.000172	0.00144	CcSEcCtD
Methadone—Dermatitis—Capecitabine—colon cancer	0.000171	0.00143	CcSEcCtD
Methadone—Headache—Capecitabine—colon cancer	0.00017	0.00143	CcSEcCtD
Methadone—Feeling abnormal—Methotrexate—colon cancer	0.000167	0.0014	CcSEcCtD
Methadone—Fentanyl—ABCB1—colon cancer	0.000166	0.0942	CrCbGaD
Methadone—Gastrointestinal pain—Methotrexate—colon cancer	0.000166	0.00139	CcSEcCtD
Methadone—Nausea—Capecitabine—colon cancer	0.000162	0.00135	CcSEcCtD
Methadone—Urticaria—Methotrexate—colon cancer	0.000161	0.00135	CcSEcCtD
Methadone—Body temperature increased—Methotrexate—colon cancer	0.00016	0.00134	CcSEcCtD
Methadone—Abdominal pain—Methotrexate—colon cancer	0.00016	0.00134	CcSEcCtD
Methadone—Loperamide—ABCB1—colon cancer	0.00016	0.0907	CrCbGaD
Methadone—Hypersensitivity—Methotrexate—colon cancer	0.000149	0.00125	CcSEcCtD
Methadone—Asthenia—Methotrexate—colon cancer	0.000145	0.00122	CcSEcCtD
Methadone—Pruritus—Methotrexate—colon cancer	0.000143	0.0012	CcSEcCtD
Methadone—Diarrhoea—Methotrexate—colon cancer	0.000139	0.00116	CcSEcCtD
Methadone—ABCB1—lymph node—colon cancer	0.000135	0.00348	CbGeAlD
Methadone—Dizziness—Methotrexate—colon cancer	0.000134	0.00112	CcSEcCtD
Methadone—Vomiting—Methotrexate—colon cancer	0.000129	0.00108	CcSEcCtD
Methadone—Rash—Methotrexate—colon cancer	0.000128	0.00107	CcSEcCtD
Methadone—Dermatitis—Methotrexate—colon cancer	0.000128	0.00107	CcSEcCtD
Methadone—Headache—Methotrexate—colon cancer	0.000127	0.00106	CcSEcCtD
Methadone—Nausea—Methotrexate—colon cancer	0.00012	0.00101	CcSEcCtD
Methadone—Trimipramine—ABCB1—colon cancer	0.00012	0.0681	CrCbGaD
Methadone—Promethazine—ABCB1—colon cancer	0.000115	0.0656	CrCbGaD
Methadone—Tamoxifen—ABCB1—colon cancer	0.000115	0.0651	CrCbGaD
